Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer. [electronic resource]

By:

Liu, Keyuan

Contributor(s):

Zhang, Jing
Wang, Hao

Producer: 20181214Description: e22611 p. digitalISSN:

1098-2825

Subject(s):

Antineoplastic Agents -- therapeutic use
Carcinoma, Non-Small-Cell Lung -- drug therapy
Cysteine Endopeptidases -- genetics
Female
Gene Expression Regulation, Neoplastic -- drug effects
Humans
Lung Neoplasms -- drug therapy
Male
Middle Aged
RNA, Messenger -- metabolism
Retrospective Studies
Risk Factors
Survival Analysis

Online resources:

Available from publisher's website

In: Journal of clinical laboratory analysis vol. 32

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Browse results Close

Back to results

1 Parkia biglobosa seeds possess anti platelet activity.
by Rendu, F
2 Platelet procoagulant activity is independent of aggregation.
by Rendu, F
3 A novel nonsense mutation in the antithrombin III gene (Cys-4-->stop) causing recurrent venous thrombosis.
by Saleun, S
4 Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells.
by Duisit, G
5 Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
by Boeri, N
6 Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitors.
by Bachelot, C
7 Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3.
by Bouyge-Moreau, I

Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer.

APA

Liu K., Zhang J. & Wang H. (20181214). Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer. : Journal of clinical laboratory analysis.

Chicago

Liu Keyuan, Zhang Jing and Wang Hao. 20181214. Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer. : Journal of clinical laboratory analysis.

Harvard

Liu K., Zhang J. and Wang H. (20181214). Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer. : Journal of clinical laboratory analysis.

MLA

Liu Keyuan, Zhang Jing and Wang Hao. Small ubiquitin-like modifier/sentrin-specific peptidase 1 associates with chemotherapy and is a risk factor for poor prognosis of non-small cell lung cancer. : Journal of clinical laboratory analysis. 20181214.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC